|
Volumn 91, Issue 2, 2002, Pages 181-187
|
Graft immunogenicity revisited: Relevance of tissue-specific immunity, brain death and donor pretreatment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CATECHOLAMINE;
DOPAMINE;
HEME OXYGENASE INHIBITOR;
HLA A3 ANTIGEN;
HLA B35 ANTIGEN;
INTERCELLULAR ADHESION MOLECULE 1;
INTERLEUKIN 6;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
NORADRENALIN;
PROTOPORPHYRIN COPPER;
PROTOPORPHYRIN ZINC;
RANTES;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
VASCULAR CELL ADHESION MOLECULE 1;
ANTIGEN EXPRESSION;
ARTERY INTIMA PROLIFERATION;
BRAIN DEATH;
CYTOKINE PRODUCTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNITY;
IMMUNOGENICITY;
KIDNEY ALLOGRAFT REJECTION;
KIDNEY TRANSPLANTATION;
KIDNEY TUBULE;
KIDNEY TUBULE CELL;
MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
TISSUE SPECIFICITY;
DONOR;
EDITORIAL;
GRAFT REJECTION;
IMMUNOLOGY;
BRAIN DEATH;
GRAFT REJECTION;
HUMAN;
KIDNEY TRANSPLANTATION;
SUPPORT, NON-U.S. GOV'T;
TISSUE DONORS;
HUMANS;
|
EID: 0036016882
PISSN: 00282766
EISSN: None
Source Type: Journal
DOI: 10.1159/000058390 Document Type: Review |
Times cited : (13)
|
References (47)
|